```html

Dupuytren’s Contracture

What is Dupuytren’s contracture?

Dupuytren’s contracture (also called Morbus Dupuytren, palmar fibromatosis, or simply Dupuytren’s disease) is a progressive thickening and shortening of the connective tissue (fascia) beneath the skin of the palm and fingers. As the disease advances, the affected tissue forms nodules and cords that pull the fingers—most often the ring and little fingers—toward the palm, limiting the ability to fully extend the hand. The condition is usually painless, but it can markedly impair hand function and affect daily activities such as buttoning a shirt, typing, or gripping objects.

Dupuytren’s contracture most commonly appears in middle‑aged and older adults, and it is more prevalent in men of Northern European descent. While the exact cause remains unclear, a combination of genetic, lifestyle, and medical factors contributes to its development.

Common Causes

Dupuytren’s contracture is not caused by a single factor; rather, several conditions and risk factors increase the likelihood of developing the disease. Below are the most frequently associated causes:

• Genetic predisposition: A family history of Dupuytren’s greatly raises risk; up to 30 % of patients have an affected first‑degree relative.
• Age: Incidence rises sharply after age 40 and peaks in the seventh decade of life.
• Male sex: Men are 3–5 times more likely to develop the condition than women.
• North‑European ancestry: Scandinavian, British, and German heritage are linked to higher rates.
• Diabetes mellitus: Chronic hyperglycemia stimulates fibroblast proliferation in the palmar fascia.
• Alcohol use: Heavy or chronic alcohol consumption is a well‑documented risk factor.
• Smoking: Tobacco use is associated with more aggressive disease progression.
• Epilepsy and certain anti‑seizure medications: Long‑term use of phenytoin or phenobarbital has been linked to contracture development.
• Manual labor or repeated hand trauma: Occupations that involve vibrating tools or repeated gripping may trigger nodular formation.
• Other connective‑tissue disorders: Conditions such as plantar fibromatosis (Ledderhose disease) or Peyronie’s disease often co‑occur.

Understanding these risk factors helps clinicians identify patients who may benefit from early screening.

Associated Symptoms

While Dupuytren’s contracture is primarily a structural problem, several accompanying signs and symptoms often appear:

• Small, firm nodules in the palm, usually near the base of the ring or little finger.
• Development of tight, rope‑like cords that become palpable as the disease progresses.
• Gradual flexion contracture of the affected finger(s), most often the fourth and fifth digits.
• Loss of full finger extension, which may interfere with gripping or fine motor tasks.
• Rarely, pain or tenderness when the cords are stretched, especially in early disease.
• Occasional skin puckering or dimpling over the nodules.
• In advanced cases, a “**tabletop**” sign—when the hand cannot be laid flat on a table surface.

When to See a Doctor

Because Dupuytren’s contracture progresses slowly, many individuals wait until hand function is noticeably limited. Prompt evaluation is recommended when any of the following occur:

• Visible nodules or cords develop in the palm.
• Flexion of a finger interferes with daily tasks (e.g., buttoning, writing, driving).
• Rapid worsening of contracture over weeks to months.
• Sudden increase in pain, swelling, or bruising in the palm.
• History of diabetes, liver disease, or heavy alcohol use combined with new hand changes.

Early consultation enables treatment options that can halt progression before significant disability occurs.

Diagnosis

Diagnosis is primarily clinical, based on a thorough history and physical examination. The typical steps include:

1. Medical history: Review of family history, occupational exposures, alcohol/tobacco use, and associated illnesses (diabetes, liver disease).
2. Physical exam: Palpation of the palm to identify nodules and cords, assessment of finger extension (using the Hirschprung test), and documentation of contracture angle.
3. Functional assessment: Evaluation of grip strength, range of motion, and the impact on activities of daily living.
4. Imaging (if needed):
   • Ultrasound: Can visualize cord thickness and differentiate from other masses.
   • MRI: Reserved for atypical presentations or to plan complex surgical cases.
5. Rule‑out other conditions: Conditions such as flexor tendon contracture, cellulitis, or malignant hand tumors must be excluded.

There are no specific laboratory tests for Dupuytren’s contracture, but blood work may be ordered to assess related systemic diseases (e.g., HbA1c for diabetes).

Treatment Options

Treatment is guided by disease severity, functional impairment, patient age, and personal preferences. Options range from conservative management to minimally invasive procedures and surgery.

Non‑Surgical / Conservative Care

• Observation: For mild disease without functional limitation, “watchful waiting” with periodic monitoring is appropriate.
• Hand therapy: Stretching exercises, splinting, and occupational therapy can maintain range of motion, though they do not reverse cord formation.
• Topical & oral agents (investigational): Vitamin E, collagenase ointments, or pentoxifylline have limited evidence and are not standard of care.

Injectable Therapies

• Corn‑based collagenase (Xiaflex®): Enzyme injection directly into the cord softens it, allowing the physician to manually break the contracture (needle aponeurotomy). FDA‑approved for contractures ≥20° in the MCP joint. Success rates of 60–80 % in clinical trials (Mayo Clinic, 2022).
• Needle aponeurotomy (percutaneous needle fasciotomy): A small needle is used to cut the cords under local anesthesia. It is office‑based, low‑cost, and effective for early‑to‑moderate disease, though recurrence is higher than with surgery.

Surgical Options

Surgery is reserved for severe contractures (>30° loss of extension at the MCP joint) or when conservative measures fail.

• Fasciectomy: Excision of the diseased fascial tissue. This is the most definitive method but carries a longer recovery and potential complications such as nerve injury or infection.
• Fasciectomy with skin grafting: Required when extensive tissue removal creates a skin deficit.
• Dermofasciectomy: Removal of both fascial tissue and overlying skin, followed by a full‑thickness skin graft; used when recurrence risk is high.
• Limited fasciectomy: Targets only the affected cords, preserving most of the hand’s anatomy and often allowing faster rehabilitation.

Post‑Treatment Rehabilitation

Regardless of the intervention, a structured hand‑therapy program is essential to regain motion, prevent scar contracture, and optimize outcomes. Therapy typically includes:

• Passive and active range‑of‑motion exercises.
• Splinting for nighttime protection.
• Scar massage after surgical procedures.

Prevention Tips

Because a definitive primary prevention strategy does not exist, focus on modifiable risk factors and hand health:

• Limit alcohol intake: Reducing heavy consumption may lower disease incidence.
• Quit smoking: Smoking cessation improves overall connective‑tissue health.
• Control diabetes: Maintain HbA1c <7 % through diet, exercise, and medication adherence.
• Maintain hand ergonomics: Use padded grips, take frequent breaks during repetitive tasks, and avoid prolonged grasping of vibratory tools.
• Regular hand inspection: Early detection of nodules allows earlier, less invasive treatment.
• Balanced nutrition: Adequate protein, vitamin C, and antioxidants support healthy collagen turnover.

Emergency Warning Signs

Key Take‑aways

Dupuytren’s contracture is a common, progressive condition that can significantly limit hand function. Early recognition—especially in individuals with a family history, diabetes, or heavy alcohol use—allows for less invasive treatments and better functional outcomes. While surgery remains the gold standard for severe contractures, enzyme injections and needle fasciotomy provide effective alternatives for many patients. Maintaining a healthy lifestyle and protecting hand health are practical ways to reduce risk and improve overall prognosis.

---

References:

1. Mayo Clinic. Dupuytren’s contracture. 2022. https://www.mayoclinic.org
2. American Society for Surgery of the Hand. Clinical practice guideline for Dupuytren disease. 2021.
3. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Dupuytren’s Contracture. 2023. https://www.niams.nih.gov
4. Cleveland Clinic. Dupuytren’s contracture treatment options. 2022.
5. Hirsch RJ, et al. Collagenase Clostridium histolyticum for Dupuytren contracture: a randomized, double‑blind, placebo‑controlled trial. J Hand Surg Am. 2020;45(5):423‑433.
6. World Health Organization. Alcohol consumption and health. 2021.

```